COMPANY
FDA-cleared device company
Location: Memphis, TN · source · Oct 14, 2026
Profile checked Oct 10, 2026
Keywords: Tympanic Membrane Perforation Tympanoseal
Timeline
- FDA FDA 510(k) clearance: Tympendi (810) — K260266, Aug 18, 2026. Applicant at approval: Grace Medical, Inc. source ↗
- Trial start Not phased (device or behavioral study): Tympanoseal Clinical Study source ↗
- Trial start —: Tympanoseal (Tympanic Membrane Device) Clinical Study source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT02918942 | Tympanoseal (Tympanic Membrane Device) Clinical Study | Not listed | Completed | Oct 4, 2016 | Sep 30, 2021 (actual) |
| NCT05849844 | Tympanoseal Clinical Study | Not phased (device or behavioral study) | Recruiting | Jan 5, 2024 | Apr 20, 2026 (estimated) |
FDA records (last 2 years)
- FDA 510(k) clearance: Tympendi (810) — K260266, Aug 18, 2026. Applicant at approval: Grace Medical, Inc. source ↗
NIH awards 1
Annual award amounts. Total $158K.
- NIH award 1R43DC011715-01 FY2011: $157,910 awarded for that fiscal year; activity R43 (SBIR); PI PRITCHARD, WILSON CANNOY; recipient as written: GRACE MEDICAL, INC., MEMPHIS, TN. Molded Hydrogel Tympanic Membrane Rep source ↗
Connect
See your connections at Grace Medical on LinkedIn (search by name, results not checked)LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-12
